Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Lessons from the failure and recall of an implantable cardioverter-defibrillator.

Hauser RG, Maron BJ.

Circulation. 2005 Sep 27;112(13):2040-2. Epub 2005 Sep 19. No abstract available.

2.

[Recall actions for implantable defibrillators -- how do you counsel your defibrillator patients now?].

Lüderitz B.

MMW Fortschr Med. 2005 Aug 18;147(33-34):8-9. German. No abstract available.

PMID:
16138625
3.
4.

Malfunctions in implantable cardiac devices: putting the risk in perspective.

Burkhardt JD, Wilkoff BL.

Cleve Clin J Med. 2005 Sep;72(9):736, 738, 742 passim. Review. No abstract available.

PMID:
16193821
5.

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

Tung R, Zimetbaum P, Josephson ME.

J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058. Review.

6.

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.

Heart. 2009 May;95(9):709-14. doi: 10.1136/hrt.2008.150656. Epub 2009 Mar 11.

PMID:
19282314
7.

[Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].

Manovel-Sánchez AJ, Pedrote-Martínez A, Arana-Rueda E, Errazquin-Sáenz de Tejada F.

Rev Esp Cardiol. 2007 Jul;60(7):784; author reply 785. Spanish. No abstract available.

9.

[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].

Disertori M.

G Ital Cardiol (Rome). 2011 May;12(5):374-8; discussion 378. doi: 10.1714/643.7503. Review. Italian. No abstract available.

PMID:
21593957
10.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

PMID:
19752408
11.

Implantable cardioverter defibrillators in children.

Chun TU, Collins KK, Dubin AM.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):561-71. Review.

PMID:
15225115
12.

Management of recalled pacemakers and defibrillators.

Cavagna M, Strickberger SA.

Expert Rev Cardiovasc Ther. 2006 Sep;4(5):601-3. No abstract available.

PMID:
17081081
14.

Transvenous implantable cardioverter-defibrillator leads: the weakest link.

Maisel WH.

Circulation. 2007 May 15;115(19):2461-3. No abstract available.

15.

Sudden cardiac death: Twiddler's syndrome with an implantable cardioverter defibrillator.

Avitall B, Stormo A, Barragry T, Axtel K, Hare J.

Am Heart J. 1994 Oct;128(4):833-6. No abstract available.

PMID:
7942458
16.
17.

Correct a statement in the article by Hauser et al. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads.

Stanton MS.

Pacing Clin Electrophysiol. 2003 May;26(5):1299; author reply 1299. No abstract available.

PMID:
12765463
18.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.

Raj SR, Mitchell LB, Sheldon RS.

N Engl J Med. 2000 Jul 6;343(1):68-9. No abstract available.

19.
20.

[Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].

Maron BJ.

Rev Esp Cardiol. 2006 Jun;59(6):527-30. Spanish. No abstract available.

Supplemental Content

Support Center